Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
5
0
0
Imago BioSciences, Inc. Share · US45250K1079 · IMGO (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Imago BioSciences, Inc.
Analyst Grade Summary
No Price
Company Profile for Imago BioSciences, Inc. Share
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Company Data
Name Imago BioSciences, Inc.
Company Imago BioSciences, Inc.
Symbol IMGO
Website
https://www.imagobio.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US45250K1079
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Hugh Young Rienhoff Jr.,
Country United States of America
Currency USD
Employees 0,0 T
Address 329 Oyster Point Boulevard, 94080 South San Francisco
IPO Date 2021-07-16
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | IMGO |
More Shares
Investors who hold Imago BioSciences, Inc. also have the following shares in their portfolio:
